Fei Li

2.6k total citations
146 papers, 1.5k citations indexed

About

Fei Li is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Fei Li has authored 146 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Hematology, 42 papers in Oncology and 36 papers in Pathology and Forensic Medicine. Recurrent topics in Fei Li's work include Lymphoma Diagnosis and Treatment (25 papers), Multiple Myeloma Research and Treatments (18 papers) and Hematopoietic Stem Cell Transplantation (17 papers). Fei Li is often cited by papers focused on Lymphoma Diagnosis and Treatment (25 papers), Multiple Myeloma Research and Treatments (18 papers) and Hematopoietic Stem Cell Transplantation (17 papers). Fei Li collaborates with scholars based in China, United States and Canada. Fei Li's co-authors include Mu Hao, Ye Yang, Lugui Qiu, Yan Xu, Lugui Qiu, Hong Chang, Jahangir Abdi, Yijun Yang, Manujendra N. Saha and Pu Li and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Fei Li

132 papers receiving 1.5k citations

Peers

Fei Li
Comparison fields: 5 of 99
  • Hematology 648
  • Molecular Biology 546
  • Cancer Research 366
  • Immunology 344
  • Oncology 269
Replace Wanzhuo Xie with:
Wanzhuo Xie China
Nicola Fracchiolla Italy
Valentina Giudice Italy
Eric Van Den Neste Belgium
Holger W. Auner United Kingdom
Hsiu‐Hao Chang Taiwan
D Niethammer Germany
Siddhartha Ganguly United States
Bernard Grillet Netherlands
Tanya Trippett United States
Wanzhuo Xie China View profile →
Citations per field, relative to Fei Li
Fei Li · 1×
Citations per year, relative to Fei Li
Fei Li · 1×

Countries citing papers authored by Fei Li

Since Specialization
Citations

This map shows the geographic impact of Fei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Li more than expected).

Fields of papers citing papers by Fei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Li. The network helps show where Fei Li may publish in the future.

Co-authorship network of co-authors of Fei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Li. A scholar is included among the top collaborators of Fei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Li. Fei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 3
3 7
4 1
5 1
6 4
7 7
8 0
9 2
10 8
11 7
12 8
13 100
14 1
15 41
16 22
17 2
18
A novel missense mutation of bovine lipase maturation factor 1 (LMF1) gene and its association with growth traits
2
19 16
20 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026